SCHEMBL4745002

SCHEMBL4745002

COCCCNCc1cc2cc(C)ccc2[nH]c1=O

nearest known ligand 0.67

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 10/20 0.67
KDM4E B2RXH2 9/20 0.67
MAPT P10636 6/20 0.67
HPGD P15428 3/20 0.67
TDP1 Q9NUW8 1/20 0.67
HSD17B10 Q99714 6/20 0.58
GAA P10253 4/20 0.58
ALOX15 P16050 2/20 0.58
CASP1 P29466 2/20 0.58
CASP7 P55210 2/20 0.58
POLB P06746 3/20 0.52
MEN1 O00255 3/20 0.51
KMT2A Q03164 3/20 0.51
TAAR1 Q96RJ0 2/20 0.51
IDH1 O75874 1/20 0.50
APAF1 O14727 1/20 0.46
NPC1 O15118 1/20 0.46
MAPK1 P28482 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
HIF1A Q16665 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4746162 0.85 KDM4E (0.70) ALDH1A1KDM4EMAPTHPGDTDP1
SCHEMBL4746075 0.77 KDM4E (0.65) ALDH1A1KDM4EMAPTHPGDTDP1
SCHEMBL4114418 0.76 KDM4E (0.71) ALDH1A1KDM4EMAPTHPGDTDP1
SCHEMBL22184914 0.74 KDM4E (0.72) ALDH1A1KDM4EMAPTHPGDTDP1
SCHEMBL27764047 0.71 KDM4E (0.64) ALDH1A1KDM4EMAPTHPGDTDP1
SCHEMBL30705712 0.68 KDM4E (0.59) ALDH1A1KDM4EMAPTHPGDTDP1
SCHEMBL17603336 0.67 IDH1 (1.00) IDH1
SCHEMBL13664567 0.67 KDM4E (0.58) ALDH1A1KDM4EMAPTHPGDHSD17B10
SCHEMBL16381141 0.66 DAO (0.68) ALDH1A1KDM4EMAPTHPGDTDP1
SCHEMBL12082628 0.65 ALDH1A1 (0.61) ALDH1A1KDM4EMAPTHPGDTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2008113006-A1 METHODS OF USING QUINOLINONE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-09-18 WO claimed
WO-2008113006-A1 METHODS OF USING QUINOLINONE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-09-18 WO disclosed
WO-2008113006-A1 METHODS OF USING QUINOLINONE COMPOUNDS IN TREATING SODIUM CHANNEL-MEDIATED DISEASES OR CONDITIONS XENON PHARMACEUTICALS INC. (CA) 2008-09-18 WO disclosed